Products for Research Use Only
RegisterLogin

Ulodesine succinate anhydrous

CAT: 0931-T202983-01Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T202983-01Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
1246200-39-4
Bioactivity
Ulodesine (also known as BCX4208) is a purine nucleotide phosphorylase (PNP) inhibitor being developed by Biocryst for the treatment of gout. Intended as a once-daily oral therapy, it functions by impacting the purine metabolic pathway upstream of xanthine oxidase to decrease serum uric acid (sUA) levels. Its half-maximal inhibitory concentration (IC (50) ) for PNP is 0.5 nM. Currently, BCX-4208 is in early clinical trials to evaluate its potential benefits in treating psoriasis and gout.
Smiles
OC(CCC(O)=O)=O.O=C(N=CN1)C2=C1C(CN3C[C@@H]([C@H](C3)O)CO)=CN2.O=C(N=CN4)C5=C4C(CN6C[C@@H]([C@H](C6)O)CO)=CN5
Molecular Formula
C12H16N4O3 1/2C4H6O4
Molecular Weight
323.325
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Related Products

CatalogName
T67822L-01Ulodesine
T67915-01Succinate/succinate receptor antagonist 1
T202089-01Napsagatran anhydrous
T69105-01Methyldopa anhydrous
T28955-01Tezampanel (anhydrous)
T25004-01Advantame anhydrous
TYD-01440-01Diammonium succinate
T72749-01E7090 succinate
T71897-01Vatalanib succinate
T11824Lanraplenib succinate

Alternative Products

CatalogName
GTR19242501-01Ulodesine succinate anhydrous
FD45364-01Disodium succinate - anhydrous
MBS5810403Ulodesine
MA-0134Succinate
3121945Dextrose anhydrous (D-Glucose anhydrous)
3121995D-Gluose anhydrous (Dextrose anhydrous)
3121975D-Glucose anhydrous (Dextrose anhydrous)
MBS5810489Succinate/succinate receptor antagonist 1
3121980D-Glucose anhydrous A.R. (Dextrose anhydrous)
3121955Dextrose anhydrous A.R. (D-Glucose anhydrous)

Popular Products